The effect of addition NaCI 150 mOsmol pH 7 on liposomes Tetraether Lipid (EPC-TEL 2,5) with sonicat

International Journal of Current Medical Science and Dental Research (IJCMSDR) Volume 1 Issue 2 Ç July-August 2019 Ç PP 01-07 ISSN: 2581-866X || www.ijcmsdr.com

The effect of addition NaCI 150 mOsmol pH 7 on liposomes Tetraether Lipid (EPC-TEL 2,5) with sonication 1,

Yulhasri, 2,Widya Safitri, 3,Erni H Purwaningsih, 4,Kusmardi Kusmardi 1,2,3,4, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia

ABSTRACT:As a drugs carrier, liposome can alter the pharmacokinetics of the entrapped drugs. Thus, drugs can act directly on the targeted cell while their systemic side effects are reduced. To become an effective drugs carrier, liposome must reach its stability in chemical, physical, and biological conditions. Liposome stability can be achieved by changing the lipid composition, such as EPC-TEL 2,5 which is made from the combination of Egg Yolk Phosphatydyl Coline (EPC) and TEL 2,5 mol % that is extracted from Thermoplasma acidofilum.

The aim of this study is to test the chemical stability of liposome EPC-TEL 2,5 with sonication by addition of NaCI 150 mOsmol pH 7 solution. The increase in number of liposome larger than 100 nm is the stability parameter in this study. After observation at day 0, 7, 30, 60, 90, there was no significant increase in the number of liposome larger than 100 nm after addition of NaCI 150 mOsmol pH 7 compared with control.

KEYWORDS:EPC-TEL 2,5, Liposome, Thermoplasma acidofilum, NaC1 150 mOsmol pH 7

I.

INTRODUCTION

It is undeniable that the use of high-dose long-term medicines for certain diseases such as Systemic Lupus Erythematosus, nephrotic syndrome, cancer or post-organ transplantation still causes various problems, especially in terms of the side effects of their use. The drugs used for the treatment of these diseases are generally very toxic such as corticosteroids, cyclosporine, methotrexate etc. These drugs can suppress the immune system and cause a variety of adverse side effects such as the appearance of seconder infection. By utilizing technological developments, especially in the field of pharmacology, various efforts have been found to reduce the side effects of drugs, one of them is by incorporating drugs into drug carriers. 1-5 One of the drug carriers that is widely developed and proven to be able to reduce drug side effects to a minimum is liposomes.

Drugs that are incorporated into the liposome will be changed pharmacokinetics, so that the drugs can be concentrated in the target cell or organ while the amount of the drug in another place that allows the occurrence of side effects will decrease. 6,7 Liposomes are a nanotechnology product that was discovered about 4 decades ago. Until now liposomes have been widely used as a multifunctional tool in various scientific fields, including one in the health and pharmaceutical fields. Applications in the health sector use 80-200 nm liposomes and must meet the exact requirements, including; lipid and drug concentration, liposome size distribution, pH, and osmolarity. 8,9 One of the conditions is distribution, obtained by extrusion through a polycarbonate membrane 100-200 nm or sonication using water probes or sonication.10-11 Another requirement is that liposomes can be used as drug carriers, which must be proven to be chemically, physically and biologically stable. Liposomes that are physically, chemically and biologically stable will bring the drug to the target better.

Stability is a major problem faced in efforts to develop liposomes. The liposomes that were first developed have not been profitable because the stability is still low and the half-life is short even though it is stored in the cooling phase. To get a stable liposome and fulfill the requirements as a drug carrier, several manipulations can be carried out such as changing the shape, size and composition. 12 The main components that make up the structure of liposomes are phospholipids and cholesterol which can come from nature or synthetically. One type of substance that promises to produce stable liposomes is a tetraeter lipid derivative obtained from natural sources. 13-14 Lipid tetraeter is the result of destruction of the Archaeabacteria membrane, including from Sulfolobus acidocalcidarius or Thermoplasma acidophilum. Based on previous research by Freisleben et al., It was proved that TEL from Thermoplasma acidophilum was not toxic, not mutagenic or antimutagenic in acute toxicity tests 15-16. One of the liposome formulations currently being developed is EPC-TEL 2.5 liposomes. 17 EPC-TEL 2.5 liposomes composed of egg yolk Phosphatidylcholine (EPC) and Lipid Tetraeter lipids (TEL) derived from the bacterium Thermoplasma acidolilum. 18 The results of the study by Purwaningsih et al. EPCTEL 2.5 liposomes using TEL from Sulfolobus acidocalcidarius have been shown to bind the drug methylprednisolone palmitate better, show therapeutic effects, and are well distributed in organs compared to controls. 19-20 However, this study has not been equipped with stability tests which are the main requirements for

|Volume 1| Issue 2 |

www.ijcmsdr.com

|1|

The effect of addition NaCI 150 mOsmol pH 7 on liposomes… liposomes as drug carriers. To prove that EPC-TEL 2.5 liposomes remain stable or more stable as chemical carriers compared to other liposomes, further research is needed on the stability test.

In this study, researchers chemically tested EPC-TEL 2.5 liposome stability. The study was carried out by adding NaC1 150 mOsmol salt pH 7 to the liposomes that had been modified and stored at 4 ° C and incubated at a certain time. If proven to be stable, it is hoped that this formulation liposome can be used as a drug carrier for long-term therapy so that the drug can be more effective even with low doses and adverse side effects can be reduced as low as possible.

II.

METHODS

Making a solution of NaCl 150 mOsmol pH 7The NaC1 150 mOsmol solution was made by mixing 175.5 mg of NaCI salt into the aquabidest liquid. The degree of acidity of the desired solution is obtained by adding a solution of NaOH and HCl. At the pH of the solution> 7, the solution must be added to the HCI solution and vice versa if the pH of the solution is <7, then the solution is added to the NaOH solution. After obtaining the desired pH, the aquabidest liquid is added to reach a volume of 20 ml (according to calculations).

Making Liposome Preparations : The liposome solution needed is as much as 50 ml. In every 1 ml of liposome solution, EPC is needed as much as 10 mMolar, so EPC required is 390 mg. TEL is needed as much as 2.5% of mMolar EPC, so that TEL is needed as much as 0.25 mMolar or as much as 18.605 mg. Buchi Rotavapor is heated, then pour the water into the waterbath with the appropriate amount so that the pumpkin can be submerged. EPC and TEL (2.5% TEL levels of EPC moles) were weighed according to calculations. EPC and TEL were mixed then Cloroform and ethanol were added with a ratio of 1: 1 (5 ml each). Put a mixture of EPC-TEL, Cloroform, Ethanol into a pumpkin containing beads. The mixture is dispersed with Buchi Rotavapor for 2 hours. The water in the waterbath must be 40 ° C and the pressure on the vacuum is maintained at 200 barrels and after drying the pressure on the vacuum is maintained below 50 barr. After the mixture dries, add Aquadest until the volume reaches 50 ml (according to the required volume), then rotate again until homogeneous. The homogeneous mixture is divided into 3 parts (each containing 15 mI) then labeled into sample I (control), II (sonication) and III (extrusion). Sample II was given treatment in the form of sonication carried out in the Department of Pharmacology FMUI for 100 minutes. After being treated, Quinacrine was added to the sonication sample according to the calculations. Liposomes that have been sonicated and given Quinacrine are divided into 2 parts, each of which is 2 ml. Both parts are labeled with the label Control and pH NaCl 7. Added a pH 7 NaCl solution with a ratio of 1: 1 to the liposome that matches the label, except the control.

Measurement and Calculation of Liposomes : Calculation of the number of liposomes and the estimated size of liposomes is done manually based on a predetermined scale. There were 2 categories of liposome sizes: <100 nm and> 100 nm. The measurement and calculation of the number of liposomes is carried out on days 0, 7, 30, 60 and 90 according to the following steps. Prepared glass is cleaned using 70% alcohol and the microscope is prepared for data collection. The measuring line is determined to measure the size of the liposome. A total of 25 µL liposomes mixed with Quinacrine were dropped on the glass preparations. Prepared glass with liposomes is closed with a cover glass, then observed under a microscope with 40x magnification (adjustable). Every preparationare taken at 10 fields of view, then record with a duration of 15 seconds. Calculated the number of liposomes <100 nm and> 100 nm.

Statistical analysis:Data analysis was performed by 1-way ANOVA statistical analysis method.

III.

RESULT AND DISCUSSION

Liposome preparations made by mixing EPC as much as 390 mg and TEL 18.605 mg produce 50 ml EPC-TEL 2.5 liposomes. The liposomes obtained were still MLV, so to obtain a <100nm small unilamelar vesicle liposome, sonication was performed using Branson type 1510 sonicator. The number and diameter of liposomes were calculated. One of the photos is shown in Figure 1.

|Volume 1| Issue 2 |

www.ijcmsdr.com

|2|

The effect of addition NaCI 150 mOsmol pH 7 on liposomesâ&#x20AC;Ś

Figure 1. EPC-TEL 2.5 Liposomes on Day 90 (A) EPC-TEL 2.5 Liposomes with Addition of NaC1 150 mOsmol pH 7. (B) Liposomes EPC-TEL 2.5 Control.

The above liposome photo was taken on the 90th day of the study. From Figure A which is a liposome with the addition of NaC1 150 mOsmol pH 7, liposome vesicles with a number that tend to be more than the control liposomes seen in Figure B. From the calculation of the number and diameter of liposomes on the 90th day, from 10 Liposome photos taken, obtained an average number of control liposomes with a size of > 100 nm as many as 12 pieces and the average NaCI 150 mOsmol liposomes pH 7 sizes> 100 nm as many as 52.67. While for the average <100 nm liposomes as much as 163.33 for control liposomes and 169.33 for liposomes with NaCI 150 mOsmol pH 7. From these results, it can be seen that there are differences in the number of liposomes between the two treatments, where the number of liposomes measuring> 100 nm tends to be more in liposomes with NaC1 150 mOsmol pH 7 compared to controls, whereas for liposomes <100 nm in size, there is more in the control liposomes compared to NaCl 150 mOsmol liposomes pH 7.

Photographs of liposomes taken on days 0, 7, 30 and 60 are not included. Based on the calculation of the number and diameter of the liposomes for the photos, the number of liposomes was obtained in two categories, those that were> 100 nm in size and <100nm in size. The data obtained can only be divided into two categories, due to the unavailability of liposome particle gauges (particle sizers). From the data obtained starting from day 0 to day 90, there are fluctuations in the number of liposomes measuring> 100 nm and <100 nm in both treatments (control and by the addition of NaC1 150 mOsmol pH 7 (Figures 2 and Figure 3).

Figure 2. Number of Liposomes with a Diameter> 100 nm

|Volume 1| Issue 2 |

www.ijcmsdr.com

|3|

The effect of addition NaCI 150 mOsmol pH 7 on liposomesâ&#x20AC;Ś

Figure 3. Number of liposomes <100 nm in diameter From Figure 2, it can be seen that untreated liposomes (control) have the highest number of vesicles> 100 nm at 30 days, whereas for liposomes with NaCI 150 mOsmol pH 7 has the highest number of vesicles> 100 nm on 90 days. For liposomes with diameter 5 100 nm (Figure 3) in both treatments showed almost the same number on days 0, 7, 30, and 90. However, on day 60 there was an increase in the number of significant vesicles on liposomes with NaCI 150 mOsmol pH 7 Based on the data shown in this graph, it was found that the liposomes that were treated or not were of a less stable nature. Therefore to ascertain whether these liposomes are chemically stable or not, then data processing is carried out using Non-parametric statistical analysis.The size of liposomes> 100 nm is an indicator of changes in liposome stability in this study. Liposome data measuring> 100 nm will be processed processed using the Non-Parametric statistical analysis method, namely Kruskall-Wallis 1way ANOVA, while for liposomes that are <100 nm in size not analyzed in this study. This analysis method was used to compare the stability between control liposomes and NaCl 150 mOsmol liposomes pH 7.

From the results of the analysis using the Kruskall-Wallis method, there is a p value of 0.332, which states that there is no significant difference in the stability of the liposomes in each treatment during the study.Over time, various changes in liposomes can be found, such as the occurrence of chemical degradation (oxidation and hydrolysis) which causes clumping and rupture of the contents of the liposome. 20 However, this change was not found in EPC-TEL liposomes 2.5 to 90 days of storage. The TEL structure used in this formulation makes it impossible for these changes not to occur.TEL which comes from Thermoplasma acidophilum has a structure in the form of 2 polar head groups with a membrane thickness of about 4 nm (from one head to the other head), so it is expected to be able to incorporate EPC liposome membranes that resemble pegs as shown in Figure 13. 21,

24-26

Figure 13. Schematic drawing of TEL incorporation of EPC28 '3 liposome membrane

|Volume 1| Issue 2 |

www.ijcmsdr.com

|4|

The effect of addition NaCI 150 mOsmol pH 7 on liposomesâ&#x20AC;Ś The stability test of liposomes derived from TEL Thermoplasma acidophilum, as done by Freisleben HJ, is known that liposomes composed of pure TEL or liposomes with a combination of egg lecithin and high concentrations of TEL are proven to have high stability, can even be stored in infinite time and not can be penetrated by protons if the TEL concentration reaches 100%. 21 In addition, another Freisleben HJ studystated that Iiposom with TEL Thermoplasma acidophilum proved to be quite stable at a low pH compared to neutral and alkaline pH. The ability to add negative charges to the surface of the liposome membrane also makes the liposome structure more stable. 22 The use of TEL as much as 2.5 mol% in this study, is more due to safety factors for long-term use. Although TEL Thermoplasma acidophilum has been proven to be non-toxic in-vivo and in-vitro, until now, the mechanism of breakdown and metabolism of TEL in the body has not been known in-vivo mechanism.23,24,27In addition to the TEL factor used in making liposomes, pH, temperature, and size also influence the stability that occurs. 14 Neutral pH functions to slow down the hydrolysis process that occurs, consequently the structure of liposomes can be more stable.

Storage of liposomes at a low temperature of around 4 °C allows the liposomes to be stored for an infinite period of time without affecting their stability. However, this process of storing in low temperatures still causes problems, namely causing damage to liposomes by osmotic dehydration. This dehydration occurs when an extra liposomal fluid pulls out the fluid contained in the liposome core chamber. 7Cooling also causes changes in liposome transition temperature, this leads to aggregation of liposomes, formation of MLV from SLV and rupture of liposome contents.7,14. In general, the transition temperature is strongly influenced by the chain length and saturation of the fat chain. Increased saturation and chain length increase the transition temperature. At elevated temperatures, the fatty acid chain will change its conformation from the all-tran chain. Straight into the gauche conformation as seen in Figure 12. This gauche structure reduces the length of the hydrocarbon chain and decreases the thickness of the membrane. As a result the membrane becomes less dense, and its stability decreases.14

Figure 12. All-trans conformation and Gauche 14 Sonication carried out on EPC-TEL 2, 5 liposomes produces liposomes of smaller size, which is around 10-50 nm (SUV). With smaller sizes, liposomes can be more stable. In liposomes of a larger size, it is likely that the liposome membrane that is in contact with another membrane is larger, making it more likely for clumping. In addition, large-sized liposomes can experience sedimentation due to the Van der Waals force.However, some losses can still occur due to the sonication carried out on the liposome, as sonication still allows for oxidation of lipids and small size of liposomes because sonication decreases the concentration of the drug that can be carried by the liposome. For example, small liposomes, also known as small-unilarnellar vesicles, which are 25-30 nm in size, can only capture 0.3 L of water per mole of lipid compared to multi-lamellar vesicles which can carry 3 L per mole. 27 Another way that can be used to minimize the oxidation process is by adding antioxidants to the structure of liposomes (a-tocopherol and phosphatidic acid), avoiding high temperatures in the process of making and storing them and using fresh liposome constituents.NaC1 150 mOsmol pH 7 salt used in this study is useful as a liposome solvent, so it is possible for EPC-TEL 2.5 liposomes to be mixed into 0.9% NaCI physiological solution. This salt is the main electrolyte component in the body and is often used in intravenous fluid therapy.

IV.

CONCLUSION

From the results of this study it can be concluded that EPC-TEL 2.5 liposomes containing tetraeter lipid derivatives from small concentrations of Thermoplasma acidofilum bacteria proved to be chemically stable, after exposure to NaC1 150 mOsmol salt solution pH 7 for a period of 3 months of storage.

|Volume 1| Issue 2 |

www.ijcmsdr.com

|5|

The effect of addition NaCI 150 mOsmol pH 7 on liposomesâ&#x20AC;Ś Besides that there was no significant stability difference, between EPC-TEL 2,5 liposomes which added NaC1 150 mOsmol pH 7 with liposomes which were not given any treatment (control).

REFFERENCE 1.

2.

3.

4.

5.

6.

7.

8.

9.

10.

11.

12.

13.

14.

15.

16.

17.

18.

19.

20.

21.

22.

23.

Xu R, Wang Q. Combining automatic table classification and relationship extraction in extracting anticancer drug-side effect pairs from full-text articles. J Biomed Inform. 2014;53:128-35.

Xu R, Wang Q. Large-scale automatic extraction of side effects associated with targeted anticancer drugs from full-text oncological articles. J Biomed Inform. 2015;55:64-72.

Zhang W, Chen Y, Liu F, Luo F, Tian G, Li X. Predicting potential drug-drug interactions by integrating chemical, biological, phenotypic and network data. BMC Bioinformatics. 2017;18(1):18. Published 2017 Jan 5. doi:10.1186/s12859-016-1415-9.

Begum T, Ghosh TC, Basak S. Systematic Analyses and Prediction of Human Drug Side Effect Associated Proteins from the Perspective of Protein Evolution. Genome Biol Evol. 2017;9(2):337-350.

Arrigoni E, Del Re M, Fidilio L, Fogli S, Danesi R, Di Paolo A. Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins. Int J Mol Sci. 2017;18(1):104. Published 2017 Jan 6. doi:10.3390/ijms18010104.

Tiwari G, Tiwari R, Sriwastawa B, et al. Drug delivery systems: An updated review. Int J Pharm Investig. 2012;2(1):2-11.

Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S. Advances and Challenges of Liposome Assisted Drug Delivery. Front Pharmacol.

2015;6:286.

Published 2015 Dec 1. doi:10.3389/fphar.2015.00286.

Bozzuto G, Molinari A. Liposomes as nanomedical devices. Int J Nanomedicine. 2015;10:975-99.

Published 2015 Feb 2. doi:10.2147/IJN.S68861.

Sawant RR, Torchilin VP. Challenges in development of targeted liposomal therapeutics. AAPS J. 2012;14(2):303-15.

Mulligan K, Brownholland D, Carnini A, Thompson DH, Johnston LJ. AFM investigations of phase separation in supported membranes of binary mixtures of POPC and an eicosanyl-based bisphosphocholine bolalipid. Langmuir. 2010;26(11):8525-33.

Heberle FA, Feigenson GW. Phase separation in lipid membranes. Cold Spring HarbPerspect Biol.

2011;3(4):a004630. Published . doi:10.1101/cshperspect.a004630.

Sissung TM1, Goey AK, Ley AM, Strope JD, Figg WD. Pharmacogenetics of membrane transporters: a review of current approaches. Methods Mol Biol. 2014;1175:91-120. doi: 10.1007/978-1-4939-0956-8_6.

Vabbilisetty P, Sun XL. Liposome surface functionalization based on different anchoring lipids via Staudinger ligation. Org Biomol Chem. 2014;12(8):1237-44.

Zhang H, Ma Y, Sun XL. Chemically selective liposome surface glyco-functionalization. Methods Mol Biol. 2011;751:269-80. doi: 10.1007/978-1-61779-151-2_16.

Freisleben HJ, Bormann J, Litzinger DC, Lehr F. Toxicity and biodistribution of liposome of the main phospholipid from the Archaebacterium Thermoplasma acidophilum in mice. J Liposome Res 1995; 5(1): 215-23.

Freisleben HJ, Neisser C, Hartmann M, Rudolph P. Influence of the main phospholipid (MPL) from Thermoplasma acidophilum and liposome from MPL from living cells: cytotoxicity and mutagenicity. J Liposomes Res 1993; 3(3):817-33.

Gogoi M, Jaiswal MK, Sarma HD, Bahadur D, Banerjee R. Biocompatibility and therapeutic evaluation of magnetic liposomes designed for self-controlled cancer hyperthermia and chemotherapy.Integr Biol (Camb). 2017 Jun 19;9(6):555-565. doi: 10.1039/c6ib00234j.

Blesso CN. Egg phospholipids and cardiovascular health. Nutrients. 2015;7(4):2731-47. Published 2015 Apr 13. doi:10.3390/nu7042731.

Ernie HP, Freisleben HJ, Sadikin M. Peningkataninkorporasimetilprednisolon palmitate pada liposom yang mengandungtetraetil lipid dari membrane Sulfolobusacidocaldariusmembentuksediaanbaru liposomal metilprednisolon palmitate. J FarmasiIndones 202; 1(1):24-30.

Wawaimuli A, Suyatna FD, Purwaningsih EH, Dewoto HR. Peningkatanefekantiinflamasisediaanmetilprednisolondalambentukliposom. MKI 2005; 56(1):17-22.

Shimada H, Nemoto N, Shida Y, Oshima T, Yamagishi A. Complete polar lipid composition of Thermoplasma acidophilum HO-62 determined by high-performance liquid chromatography with evaporative light-scattering detection. J Bacteriol. 2002;184(2):556-63.

Siliakus MF, van der Oost J, Kengen SWM. Adaptations of archaeal and bacterial membranes to variations in temperature, pH and pressure. Extremophiles. 2017;21(4):651-670.

Koga Y. Thermal adaptation of the archaeal and bacterial lipid membranes. Archaea. 2012;2012:789652.

|Volume 1| Issue 2 |

www.ijcmsdr.com

|6|

The effect of addition NaCI 150 mOsmol pH 7 on liposomesâ&#x20AC;Ś 24.

25.

26.

27.

McCarthy S, Johnson T, Pavlik BJ, et al. Expanding the Limits of Thermoacidophily in the Archaeon Sulfolobussolfataricus by Adaptive Evolution. Appl Environ Microbiol. 2016;82(3):857-67. Published 2016 Jan 22. doi:10.1128/AEM.03225-15.

Shimada H, Nemoto N, Shida Y, Oshima T, Yamagishi A. Effects of pH and temperature on the composition of polar lipids in Thermoplasma acidophilum HO-62. J Bacteriol. 2008;190(15):5404-11.

Jain D, Basniwal PK. Forced degradation and impurity profiling: recent trends in analytical perspectives.

J Pharm Biomed Anal. 2013 Dec;86:11-35. doi: 10.1016/j.jpba.2013.07.013. Epub 2013 Jul 31.

Siliakus MF, van der Oost J, Kengen SWM. Adaptations of archaeal and bacterial membranes to variations in temperature, pH and pressure. Extremophiles. 2017;21(4):651-670.

|Volume 1| Issue 2 |

www.ijcmsdr.com

|7|